Matt Rhodes
InvestorManaging Director at 1855 Capital Partners · Board director at Phospholutions
About
Senior executive with a background spanning startup funding and leadership of a $1B+ semiconductor business. Previously President of Conexant Systems and CEO of the VC-backed startup Teranetics, and holds degrees from Penn State, Lehigh, and UCLA with deep ties to the Penn State community.
Contact· self-published, not guessed
Board director at Phospholutions
Intro paths
In turn, Matt can intro founders to Phospholutions's investors below.
Phospholutions's investors · 5
Co-founders at Phospholutions
Deals · 17
PhospholutionsSolo GP
via 1855 Capital Partners · filed Jul 2023
BenefixSolo GP
via 1855 Capital Partners · filed Nov 2019
5MetisSolo GP
Bliley TechnologiesSolo GP
Cove FundSolo GP
CroptixSolo GP
DaasitySolo GP
DatainventionsSolo GP
Magnitude InstrumentsSolo GP
Maumee VenturesSolo GP
Pledge ItSolo GP
ReflexionSolo GP
spotLESS MaterialsSolo GP
TEAMology EducationSolo GP
BlileySolo GP
Data InventionsSolo GP
TEAMologySolo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Colleagues at 1855 Capital Partners
Frequently asked questions
- Who is Matt Rhodes?
- Senior executive with a background spanning startup funding and leadership of a $1B+ semiconductor business. Previously President of Conexant Systems and CEO of the VC-backed startup Teranetics, and holds degrees from Penn State, Lehigh, and UCLA with deep ties to the Penn State community.
- Where does Matt Rhodes work?
- Matt Rhodes is Managing Director at 1855 Capital Partners and Board director at Phospholutions.